Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A severe inflammatory disease that occurs sporadically and in outbreaks in Russia and Japan, caused by Yersinia pseudotubuclosis infection, an organism that typically causes self-limiting gastroenteritis in Europe.
Biomarker and diagnostic research for Far-East scarlet-like fever has been reported in the published literature.
No clinical trials have been registered for Far-East scarlet-like fever.
3 publications have been identified in PubMed for Far-East scarlet-like fever. Research spans Diagnostic / Biomarker (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Yasuoka K (2025). [PMID: 39780644](https://pubmed.ncbi.nlm.nih.gov/39780644/). *Microbiology and immunology*. [Basic Science / Preclinical]
Kato A (2025). [PMID: 39259870](https://pubmed.ncbi.nlm.nih.gov/39259870/). *The Pediatric infectious disease journal*. [Diagnostic / Biomarker]
Suzuki S (2024). [PMID: 37839888](https://pubmed.ncbi.nlm.nih.gov/37839888/). *Internal medicine (Tokyo, Japan)*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 8:33 PM UTC
Common questions about Far-East scarlet-like fever